Publications by authors named "Nanki Bakshi"
Article Synopsis
- - Tamoxifen increases the risk of endometrial hyperplasia and cancer, but there’s not much guidance on treating this condition in breast cancer survivors.
- - The Levonorgestrel-releasing intrauterine system (LNG-IUS) is being studied as a preventive method, although its effects on breast cancer recurrence in Progesterone receptor-positive patients are uncertain.
- - Aromatase Inhibitors (AIs) may help with endometrial hyperplasia caused by tamoxifen, indicating a need for further research on their effectiveness.
Aim: This study aims to evaluate the long-term treatment outcome of conventional and hypofractionation radiotherapy in postmastectomy cancer breast patients.
Material And Methods: A total of 140 postmastectomy breast cancer patients were included in this retrospective study, who were treated from 2012 to 2014 with chemotherapy and various fractionation radiotherapy schedules. Radiotherapy treatment records for study group-I received radiotherapy 4256 cGy in 16 fractions over 3½ weeks, group-II patients received 4005 cGy in 15 fractions over 3 weeks, and conventional radiotherapy group-III received 5000 cGy in 25 fractions over 5 weeks.